P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

P915: TREATMENT PATTERNS AND CLINICAL OUTCOMES OF PATIENTS WITH MULTIPLE MYELOMA PREVIOUSLY TREATED WITH LENALIDOMIDE AND AN ANTI-CD38 MONOCLONAL ANTIBODY: FINDINGS FROM THE CONNECT MM DISEASE REGISTRY

Bibliografische gegevens
Hoofdauteurs:	Rafat Abonour, Robert Rifkin, Sikander Ailawadhi, Hans C. Lee, Christina Gasparetto, Lynne Wagner, Brian Durie, James Hardin, Howard Terebelo, Mohit Narang, Kathleen Toomey, Yuexin Tang, Sujith Dhanasiri, Jasmeet Anand, Edward Yu, Thomas Marshall, Liang Liu, Sundar Jagannath
Formaat:	Artikel
Taal:	English
Gepubliceerd in:	Wiley 2023-08-01
Reeks:	HemaSphere
Online toegang:	http://journals.lww.com/10.1097/01.HS9.0000970564.52503.e2

Gelijkaardige items

Impact of lenalidomide-bortezomib-dexamethasone induction on patients with newly diagnosed multiple myeloma and renal impairment: Results from the Connect® MM Registry
door: Sikander Ailawadhi, et al.
Gepubliceerd in: (2024-11-01)

Treatment patterns and outcomes in elderly patients with newly diagnosed multiple myeloma: results from the Connect® MM Registry
door: Hans C. Lee, et al.
Gepubliceerd in: (2021-07-01)

Connect MM Registry as a national reference for United States multiple myeloma patients
door: Sikander Ailawadhi, et al.
Gepubliceerd in: (2020-01-01)

Impact of post-ASCT maintenance therapy on outcomes in patients with newly diagnosed multiple myeloma in Connect MM
door: Sundar Jagannath, et al.
Gepubliceerd in: (2018-07-01)

Lenalidomide-Associated ITP
door: Christina I. Herold, et al.
Gepubliceerd in: (2011-01-01)

Porche 915 1969-76 autobook/
door: 206830 Ball, Kenneth
Gepubliceerd in: (1978)

Impact of prior therapy on the efficacy and safety of oral ixazomib-lenalidomide-dexamethasone vs. placebo-lenalidomide-dexamethasone in patients with relapsed/refractory multiple myeloma in TOURMALINE-MM1
door: María-Victoria Mateos, et al.
Gepubliceerd in: (2017-10-01)

Impact of prior lenalidomide or proteasome inhibitor exposure on the effectiveness of ixazomib–lenalidomide–dexamethasone for relapsed/refractory multiple myeloma: A pooled analysis from the INSURE study
door: Lee, HC, et al.
Gepubliceerd in: (2024)

9.15 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2001
door: Wurtman, Richard J., 1936-
Gepubliceerd in: (2001)

Lenalidomide before and after Autologous Hematopoietic Stem Cell Transplantation in Multiple Myeloma
door: S. A. Tuchman, et al.
Gepubliceerd in: (2012-01-01)

Carfilzomib-lenalidomide-dexamethasone in the management of lenalidomide-refractory multiple myeloma
door: C. Cerchione, et al.
Gepubliceerd in: (2020-10-01)

P901: POMALIDOMIDE, BORTEZOMIB, AND DEXAMETHASONE IN LENALIDOMIDE–PRETREATED MULTIPLE MYELOMA: A SUBANALYSIS OF OPTIMISMM BY FRAILTY
door: A. Oriol, et al.
Gepubliceerd in: (2022-06-01)

P965: FOLLOW-UP ANALYSIS OF THE RANDOMIZED PHASE II TRIAL OF BORTEZOMIB, LENALIDOMIDE, DEXAMTHASONE WITH/WITHOUT ELOTUZUMAB FOR NEWLY DIAGNOSED, HIGH RISK MULTIPLE MYELOMA (SWOG-1211)
door: S. Usmani, et al.
Gepubliceerd in: (2022-06-01)

9.15 / 9.150 Biochemistry and Pharmacology of Synaptic Transmission, Fall 2003
door: Wurtman, Richard J., 1936-
Gepubliceerd in: (2003)

915 nm pumping kilowatt fiber oscillator with high optical-to-optical efficiency
door: Xin Chen, et al.
Gepubliceerd in: (2024-11-01)

A new 915 MHz coaxial-line-based microwave plasma source
door: Robert Miotk, et al.
Gepubliceerd in: (2024-07-01)

Optimal Ate Pairing on Elliptic Curves with Embedding Degree $9,15$ and $27$
door: Emmanuel Fouotsa, et al.
Gepubliceerd in: (2020-04-01)

915 MHz microwave-assisted laparoscopic partial splenectomy: A case series
door: Qiyi Zhang, et al.
Gepubliceerd in: (2020-01-01)

A phase 2 study of panobinostat with lenalidomide and weekly dexamethasone in myeloma
door: Ajai Chari, et al.
Gepubliceerd in: (2017-08-01)

Phase 1 study combining elotuzumab with autologous stem cell transplant and lenalidomide for multiple myeloma
door: Seunghee Kim-Schulze, et al.
Gepubliceerd in: (2024-04-01)

ARTÍCULO 915 DEL CÓDIGO CIVIL: UNA SOLUCIÓN JURISPRUDENCIAL A LA LIMITACIÓN DE LAS ACCIONES TRADICIONALES Article 915 of the civil code: a jurisprudential solution to the limitation of the traditional actions
door: Arturo Selman Nahum
Gepubliceerd in: (2011-01-01)

Planned withdrawal of dexamethasone after pomalidomide low-dose dexamethasone induction for lenalidomide-refractory multiple myeloma (ALLG MM14)
door: Anna Kalff, et al.
Gepubliceerd in: (2021-09-01)

Cost-per-responder analysis of patients with lenalidomide-refractory multiple myeloma receiving ciltacabtagene autoleucel in CARTITUDE-4
door: Doris K. Hansen, et al.
Gepubliceerd in: (2024-08-01)

Coseismic slip and afterslip of the Great Mw 9.15 Sumatra-Andaman earthquake of 2004
door: Chlieh, Mohamed, et al.
Gepubliceerd in: (2012)

Measurements and Models of 915 MHz LoRa Radio Propagation in an Underground Gold Mine
door: Philip Branch
Gepubliceerd in: (2022-11-01)

Analysis of Asphericity and Corneal Longitudinal Spherical Aberration of 915 Chinese Myopic Adult Eyes
door: Zhang J, et al.
Gepubliceerd in: (2023-02-01)

Surface energy arising from the behavior of lipid molecules in the water via Γ-convergence
door: Luca Lussardi, et al.
Gepubliceerd in: (2013-01-01)

P947: COMPARATIVE EFFECTIVENESS OF ORAL IXAZOMIB-LENALIDOMIDE-DEXAMETHASONE (IRD) AFTER INITIAL BORTEZOMIB (V)-BASED INDUCTION VS PARENTERAL V-BASED THERAPY IN NEWLY DIAGNOSED MULTIPLE MYELOMA (NDMM)
door: R. M. Rifkin, et al.
Gepubliceerd in: (2022-06-01)

Adjusting for subsequent therapies in the TOURMALINE-MM1 study shows clinically meaningful improvement in overall survival with addition of ixazomib to lenalidomide and dexamethasone
door: Karthik Ramasamy, et al.
Gepubliceerd in: (2024-02-01)

Atmospheric pressure microwave (915 MHz) plasma for hydrogen production from steam reforming of ethanol
door: Robert Miotk, et al.
Gepubliceerd in: (2024-06-01)

Optimization of Nd-Doped LMA Fibers for High-Power Laser Emission Near 915 nm
door: Raphael Florentin, et al.
Gepubliceerd in: (2024-01-01)

Increased risk of lymphoid neoplasm in patients with myeloproliferative neoplasm: a study of 1,915 patients
door: Elisa Rumi, et al.
Gepubliceerd in: (2011-03-01)

The use of data from 915 MHz profilers in analysis of ozone episodes in San Diego, California
door: Virginia J. Bigler-Engler, et al.
Gepubliceerd in: (1998-12-01)

Hydrogen production by the steam reforming of synthetic biogas in atmospheric-pressure microwave (915 MHz) plasma
door: Bartosz Hrycak, et al.
Gepubliceerd in: (2023-02-01)

Potential of Sub-GHz Wireless for Future IoT Wearables and Design of Compact 915 MHz Antenna
door: Adolfo Di Serio, et al.
Gepubliceerd in: (2017-12-01)

A Small 915MHz Receiving Antenna for Wireless Power Transmission Aimed at Medical Applications
door: Toshihiro Kumagai, et al.
Gepubliceerd in: (2014-01-01)

Therapy of Angiosarcoma with Thalidomide and Lenalidomide
door: M. Jules Mattes, et al.
Gepubliceerd in: (2021-11-01)

Impact of ixazomib‐lenalidomide‐dexamethasone therapy on overall survival in multiple myeloma patients: Analysis of the emerging‐markets subgroup of the TOURMALINE‐MM1 trial
door: Andrew Spencer, et al.
Gepubliceerd in: (2022-11-01)

LENALIDOMIDE RETREATMENT IN A PATIENT WITH RELAPSED MULTIPLE MYELOMA WHO HAD PREVIOUSLY RESPONDED TO LENALIDOMIDE
door: Vincenzo Federico
Gepubliceerd in: (2014-08-01)

Phase 1 investigation of lenalidomide/rituximab plus outcomes of lenalidomide maintenance in relapsed CNS lymphoma
door: James L. Rubenstein, et al.
Gepubliceerd in: (2018-07-01)